The dismissal narrows the case to retaliation claims only, reducing potential settlement range and legal costs. Monitor discovery developments on remaining claims, but the core disability discrimination theory has been eliminated. No immediate stock impact expected.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Dec 4 $63.27entry
- T+1 · 12mo ago +1.11%α +0.92% · $63.97
- T+5 · 11mo ago +5.79%α +5.09% · $66.94
- T+20 · 11mo ago +9.48%α +8.70% · $69.27
- T+60 · 9mo ago +27.00%α +26.59% · $80.36
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The New York Times won a motion to dismiss two claims in a former employee's lawsuit: disability discrimination under the NYCHRL and FMLA interference. The court found the plaintiff's five-day COVID-19 infection did not qualify as a disability under the NYCHRL, and that she was not denied or discouraged from taking FMLA leave. The case continues on remaining claims (NYCHRL retaliation, NYLL retaliation, FMLA retaliation), but the dismissed claims remove a modest litigation overhang.
Court Ruling Details
Key Facts
- Court granted NYT's motion to dismiss NYCHRL disability discrimination and FMLA interference claims.
- Plaintiff's COVID-19 infection (5-day fever/sore throat) held insufficient to qualify as a disability under NYCHRL.
- Plaintiff received approved FMLA leave and was encouraged to take it by HR; no interference found.
- Remaining claims: NYCHRL retaliation, NYLL retaliation, FMLA retaliation, discovery ongoing.
- No damages awarded; no injunction issued; no financial exposure stated in the opinion.
Financial Impact
No damages awarded or pleaded amount stated in the opinion. Financial exposure not quantified.
Risk Factors
- Remaining retaliation claims (NYCHRL, NYLL, FMLA) could still result in damages if plaintiff prevails at trial or settlement.
- Plaintiff may appeal the dismissal of NYCHRL disability claim (though appeal prospects appear low given clear precedent).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-1q12avm9-NYT |
Track record
12 reports on NYT
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +9.32% at T+5 after the Nov 4, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $72.85 Now $73.50 +0.89% settles Dec 15
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $66.50 Now $73.50 +10.53% settles Dec 3
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $69.58 Now $73.50 −5.63% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $65.48 to $67.68 Now $73.50 +12.25% ▲ +3.36% +3.96% vs SPY
- Jun 30, 202620w ago Court Ruling Bullish 6/10 Entry $69.98 to $72.37 Now $73.50 +5.03% ▲ +3.42% +4.44% vs SPY
- Jun 30, 202620w ago Court Ruling Bullish 4/10 Entry $69.98 to $72.37 Now $73.50 +5.03% ▲ +3.42% +4.44% vs SPY
- May 11, 202627w ago Insider Cluster Neutral 3/10 Entry $74.27 to $73.80 Now $73.50 −1.03% ▼ −0.63% −2.74% vs SPY
- Apr 13, 202631w ago Court Ruling Neutral 3/10 Entry $79.30 to $77.22 Now $73.50 −7.31% ▼ −2.62% −10.35% vs SPY
- Mar 13, 202635w ago DEFA14A Neutral 3/10 Entry $78.93 to $79.30 Now $73.50 −6.87% ▲ +0.47% −3.12% vs SPY
- Mar 13, 202635w ago DEFA14A Neutral 3/10 Entry $78.93 to $79.30 Now $73.50 −6.87% ▲ +0.47% −3.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers